跳至主要内容
临床试验/NCT01382615
NCT01382615终止不适用

Evaluation of Immune Parameters and Function in Multiple Myeloma Patients and Healthy Individuals' Blood and Marrow Samples

Dartmouth-Hitchcock Medical Center1 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2010年8月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
29
试验地点
1
主要终点
Cancer cell response to molecular testing of killing cell parts.

研究概览

简要总结

The purpose of this study is to collect a blood or bone marrow sample from patients with multiple myeloma and from volunteers without myeloma.

详细描述

The blood and bone marrow samples will be used in the laboratory to perform focused studies on multiple myeloma.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participant population is multiple myeloma patients over the age of 18 who are undergoing a scheduled bone marrow collection and/or blood drawing procedure as part of their routine treatment or follow up, and healthy volunteers over the age of 18 who have agreed to have a bone marrow and/or blood harvest as part of a donation to a transplant recipient.

排除标准

  • Patients, who in the opinion of their physician, would be adversely affected by removal of an extra15ml of blood and /or an extra 10ml of bone marrow.

结局指标

主要结局

Cancer cell response to molecular testing of killing cell parts.

时间窗: 2 Years

This myeloma specific killing may help identify mechanisms, in vitro, of killing myeloma cells for the future use in clinical trials.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kenneth Meehan

Director, Bone Marrow Transplant Program

Dartmouth-Hitchcock Medical Center

研究点 (1)

Loading locations...

相似试验

Protocol to Obtain Blood and Bone Marrow Samples for... | 临床试验